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Abstract A/x-calpain-PKC complex was isolated from rabbit 
skeletal muscle by ultracentrifngation and by anion-exchange 
chromatography. The PKC associated to/t-calpain was stimu- 
lated by calcium, phosphatidylserine and diacylglycerol, and cor- 
responds to a conventional PKC (cPKC). This complex presents 
an apparent molecular mass close to 190 kDa and is composed 
of one /z-calpain molecule and of one cPKC molecule. Using 
monoclonal antibodies pecific for the different cPKC isoforms, 
the isoenzyme associated to p-calpain was identified as cPKCot. 
Immunofluorescence staining reveals a co-localization of/t-cal- 
pain and cPKCot on the muscle fibre plasma membranes. 
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1. Introduction 
Calpains are intracellular Ca2+-dependent proteases whose 
biological functions are still unknown despite their widespread 
presence in species ranging from honeybee [1] to man [2]. The 
major difficulty to determine their action in vivo, is inherent to 
the fact that their physiological substrates have still not been 
identified with certainty. Two ubiquitous isoenzymes, ¢t and 
m-calpains, with distinct calcium sensitivities in vitro, were 
originally isolated [3,4]. Recently, tissue-specific calpains have 
been identified in skeletal muscle [5] and in the stomach [6]. 
/t and m-calpains hydrolyse protein kinase C (PKC) in vitro, 
and generate an N-terminal regulatory domain and a C-termi- 
nal catalytic domain [7]. PKCs are divided into three groups [8]. 
One is Ca2+-sensitive and phorbol ester-responsive (conven- 
tional PKC0~, 81, f12, ~'), another is Ca2+-insensitive and phor- 
bol ester-responsive (novel PKC ~, e r/0) and the last group, 
called atypical, contains isoenzymes as PKC ~ ~ and t which 
are Ca2*-independent and are not activated by diacylglycerol 
or phorbol esters [9-11]. 
We have previously reported that/l-calpain co-elutes with a 
PKC activity through hydrophobic and anion exchange chro- 
matographies ofcytosolic fractions obtained from skeletal mus- 
cle [12,13]. The co-elution of ~t-calpain and PKC on these 
columns could correspond either to the presence of a multi- 
enzymatic omplex or to the fact that these enzymes have the 
same hydrophobicity and the same net charge. In order to 
clarify this point, we analysed the/l-calpain-PKC co-purifying 
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enzymes from skeletal muscle by gel filtration and by non- 
denaturing el electrophoresis and observed that these two 
enzymes were physically associated. Then, we used denaturing 
electrophoresis to assess the subunit composition of this com- 
plex. Using different cofactors, we have also determined to 
which group belonged the PKC associated with ¢t-calpain and, 
by Western blotting, we characterised the PKC isoform cor- 
responding to this group. Finally, by immunohistochemical 
analysis, we have localised ¢t-calpain and cPKC~ in the muscle 
fibre. 
2. Materials and methods 
2.1. Materials 
Casein was obtained from Merck, Darmstadt, Germany (art. 2244). 
Redivue [~'-3Zp]ATP (5000 Ci/mmol) was purchased from Amersham 
(Buckinghamshire, UK). Q-Sepharose Fast Flow and Sephacryl S-300 
HR were supplied by Pharmacia Biotech (Uppsala, Sweden). Monoclo- 
nal antibodies specific for ~ ,8 and T PKC isoenzymes (clones MC-3a, 
MC-2a and MC-Ia, respectively) were from Seikagaku Corp. (Tokyo, 
Japan). Anti-calpain polyclonal antibodies specific for the 80 kDa sub- 
units of/1 and m-calpains from rabbit were raised in goats by Dr. 
Levieux (INRA, Theix, France) and purified in our laboratory as pre- 
viously described [14]. Immobilon-P membrane was purchased from 
Millipore (Bedford, MA). Phenylmethanesulfonyl fluoride (PMSF) was 
from Fluka Chemie (Buchs, Switzerland). 1-Oleoyl-2-acetyl-rac-glyc- 
erol used as diacylglycerol, the gel calibration kits and the other chem- 
icals, were from Sigma (St. Louis, MO). 
2.2. Preparation of cytosol 
All operations were conducted at4°C. Muscles from adult, male New 
Zealand rabbits, killed by cervical dislocation, were rapidly dissected 
and homogenised in a Waring Blender, for 30 s at low-speed followed 
by 30 s at high speed, with 5 vols. of extraction buffer (30 mM Tris-HCI, 
pH 7.4, containing 250 mM sucrose, 1 mM PMSF, 10 mM benzamid- 
ine, 10 mM EGTA, 2 mM EDTA, 0.5 mM DTT and 1 mM NAN3). The 
homogenate was centrifuged at12,000 xg for 15 min. The supernatant 
was filtered through cheese-cloth oremove free-floating fat and centri- 
fuged at 100,000 x g for 60 min. The pH of the supernatant obtained 
after ultracentrifugation was adjusted to 7.4 with NaOH. The resulting 
preparation is defined as the cytosol. 
2.3. Anion-exchange chromatography 
Approximately 300 ml of cytosol (3 g protein) were loaded onto a 
Q-Sepharose fast flow column (2.6 x 11 cm) previously equilibrated 
with buffer A (30 mM Tris-HC1, pH 7.4, containing 1 mM PMSF, 
1 mM EGTA, 1 mM EDTA, 0.5 mM DTT and 1 mM NAN3). The 
column was then washed with buffer A until the outflow reached the 
baseline. The adsorbed proteins were eluted with 6 bed volumes of a 
0-250 mM NaCI linear gradient in the same buffer. An aliquot of each 
fraction was assayed for calpain and PKC activities. 
2.4. Gel filtration on Sephacryl S-300 HR 
The fractions obtained from the Q-Sepharose column and containing 
the p-calpain and PKC activities were pooled (approximately 30mg of 
protein) and concentrated on an Amicon PM 30 membrane. These 
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active fractions were loaded onto a Sephacryl S-300HR column 
(1.6 × 40 cm) previously equilibrated inbuffer A containing also 0.15 M 
NaC1 (buffer B). The proteins were eluted with buffer B at a 
flow rate of 25 ml/h. Fractions of 3 ml were collected and their en- 
zyme activities assayed. The partition coefficient Kay for calibration 
of the column was calculated as: Kay = (Ve-Vo)/(Vt-Vo) where lie = 
elution volume of the protein, V o = void volume and V t = total bed 
volume. 
2.5. Enzyme assays 
Calpain activity was assayed as described by Wolfe et al. [15] using 
fluorescein-casein as substrate and measuring the fluorescence of a 
2.5% trichloroacetic a id supernatant. Casein was labeled with fluores- 
cein isothiocyanate according to the method of Twining [16]. Fluores- 
cence was measured with a Shimadzu (Kyoto, Japan) RF-551 S spec- 
trofluorimeter using an excitation wavelength of 495 nm and an emis- 
sion wavelength of 518 nm. Specific activity was expressed as fluores- 
cence units (FU)/mg protein per min. Protein kinase C activity was 
measured as previously described using histone type III S as substrate 
[17]. 
2.6. Polyacrylamide gel electrophoresis 
Non-denaturing electrophoresis was carried out in linear 5-18% pol- 
yacrylamide gels. Samples, (50/~g/lane) were electrophoresed in a cold 
room at 4°C for 24 h, at a constant voltage of 150 V. Molecular weight 
standards were run on the same gel and included apoferritin (440 
kDa), catalase (232 kDa), lactate dehydrogenase (140 kDa) and bovine 
serum albumin (67 kDa). SDS-PAGE electrophoresis were carried 
out on 8% separating els and samples were run at 25 mA for 2 h 30 
min. 
2. 7. Immunoblotting 
The proteins obtained after gel electrophoresis were electrotransfer- 
red (2.5 mA/cm 2, 30 min) to an Immobilon-P membrane using a Milli- 
blot semi-dry electroblotter (Millipore Corp., Bedford, MA). The non- 
specific sites were blocked for 2 h at 25°C with PBS (137 mM NaCI, 
2.7 mM KC1, 10 mM phosphate buffer, pH 7.3) containing 5% (w/v) 
skim milk. After washing 4 times for 5 min in PBS, the membrane was 
incubated for 4 h at room temperature with the ~ fl or y antibodies 
diluted 1:200 with 0.1% (w/v) skim milk in PBS or with the calpain 
antibodies diluted 1:100. Antibody binding was detected with IgG 
conjugated to peroxydase (dilution 1:1000) after SDS-PAGE of the 
proteins obtained by gel filtration. After SDS-PAGE of the proteins 
obtained by non-denaturing electrophoresis, which were present in low 
quantity, the transfer membrane was incubated overnight with IgG 
conjugated to alkaline phosphatase (dilution 1 : 10 000). 
2.8. Immunohistochemical analysis 
Sectioned rabbit skeletal muscles were fixed in 4% formaldehyde for 
I h at 4°C. After washing with 20% sucrose in phosphate-buffered saline 
(PBS), the muscles were frozen in isopentane chilled by liquid nitrogen 
and sectioned at 8 pm in a cryostat at -20°C. The sections were 
disposed on glass slides coated with gelatin and incubated for 10 min 
with bovine serum albumin to block the non-specific sites. The sections 
were then incubated for l0 min in PBS containing the anti-PKC~ or 
anti-/z-calpain antibodies. Following washing, sections were incubated 
for 1 h with anti-mouse IgG or anti-goat IgG conjugated to FITC. 
Control sections lacked the primary antibodies but were treated identi- 
cally to experimental sections. Preparations were examined with 
an epiilluminated fluorescence microscope (Leitz, Wetzlar/Germa- 
ny) and photographed on Ilford HP-5 plus black and white 400 ASA 
film. 
3.  Resu l t s  
As presented in Fig. 1, p-calpain co-eluted with a PKC activ- 
ity from a Q-Sepharose column between 160 and 180 mM NaCI 
using 6 bed volumes of a 0-250 mM gradient. In agreement 
with Koohmaraie [18] we observed that, by using at least five 
column volumes of salt gradient,/.t-calpain was effectively sep- 
arated from the calpain inhibitor calpastatin. In this manner, 
calpastatin did not interfere with the measurement ofp-calpain 
activity. The m-calpain was eluted between 0.35-0.4 M NaCl 
as previously described [12], and consequently, was not present 
in the fractions eluted with the 0-250 mM gradient. Fig. 2 
shows that after gel filtration on Sephacryl S-300 HR, the 
/a-calpain and PKC co-purifying activities obtained from Q- 
Sepharose are again strictly superposed. This result is highly 
reproducible on condition that the serine-protease inhibitors 
were present in the extraction medium and during all chromat- 
ographic steps. It appears that/.t-calpain and PKC activities 
co-eluted just after fl-amylase from sweet potato (200 kDa) and 
that, after calibration of the gel filtration column, this multi- 
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Fig. 1. Chromatography of the cytosolic fraction on a Q-Sepharose column. 
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Fig. 2. Chromatography of Q-Sepharose purified extracts on a Sephacryl S-300 HR column. Inset: calibration of the Sephacryl S-300 HR column 
with: (1) chymotrypsinogen (25 kDa), (2) aldolase (158 kDa), (3)fl-amylase from sweet potato (200 kDa), (4) ferritin (443 kDa), (5) thyroglobulin 
(669 kDa). The arrow indicates the position of the/t-calpain-PKC complex. 
enzymatic complex has an apparent molecular mass of approx- 
imately 190 kDa (Fig. 2, inset). 
As shown in Fig. 3, the kinase activity present in the complex 
was both Ca 2÷ and phosphatidylserine (PS) dependent. Addi- 
tion of diacylglycerol to the assay medium, which already con- 
tained Ca 2÷ and PS, greatly enhanced kinase activity. In the 
absence of calcium, no activity was detectable in the presence 
of PS. These results imply that the PKC associated with p- 
calpain belongs to the conventional PKC (cPKC) group. 
To determine the type of cPKC present in the complex ob- 
tained after gel filtration, Western blot analysis were conducted 
with monoclonal anti-cPKC antibodies. Western blot yielded 
an immunoreactive band of around 80 kDa only with the PKCc~ 
antibody (Fig. 4). No reaction occurred with the fl or y PKC 
antibodies. These results are in agreement with a previous 
Western blot study we have carried out on /.t-calpain-PKC 
co-eluting enzymes obtained after Q-Sepharose [13]. However, 
the antibodies used for this previous experiment did not permit 
a discrimination between the a and fl isoforms as in the present 
study. 
As presented in Fig. 5A, non-denaturing gel electrophoresis 
resolves the co-purifying enzymes obtained after Q-Sepharose 
into major bands between 67 and 190 kDa. Only the 190 kDa 
band was resolved into major protein bands around 80 kDa 
(Fig. 5B), one of which being subsequently recognised by the 
p-calpain antibody, but not by the m-calpain antibody (Fig. 
5C). A 28-30 kDa band corresponding to the molecular mass 
of the small subunit of calpains appeared from time to time 
after the second dimension electrophoresis. However, due to 
the duration of the non-denaturing electrophoresis and to the 
lability of this protein, this result was not constant. A 78 kDa 
band was also recognised by the PKC~ antibody (SD). In addi- 
tion, the active fractions were shown not to contain detectable 
PKC fl or 7, using the corresponding monoclonal antibodies 
(5D)./l-calpain from rabbit is a heterodimer composed of a 80 
kDa catalytic subunit [19] and a 28 kDa subunit [20]. PKCs 
from rabbit have a relative molecular mass around 77 kDa [21]. 
All of these data imply the association of one molecule of 
/.t-calpain with one molecule of cPKCct. 
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Fig. 3. Effect of calcium, phosphatidylserine (PS) and diacylglycerol 
(DAG) on the PKC activity associated to ,u-calpain. Results were nor- 
malised to the maximum activity obtained in the presence of CaCI2 (0.2 
mM), PS (20 ltg/ml) and DAG (2 pg/ml). 
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anti-cPKC~ antibodies reveals a co-localization of these 
enzymes in muscle sarcolemma (Fig. 6A,B). Moreover,/t-cal- 
pain and cPKC~ were always absent from cytoplasm in the 
various sections of myotubes that we have observed. Concern- 
ing the localisation of cPKC~, these results obtained with skel- 
etal muscle from rabbit are in agreement with those of Nakano 
et al. [22], who report also the presence of the cPKC~ isoen- 
zyme on the surface of the plasma membrane in human skeletal 
muscle. 
4. Discussion 
In previous papers [12,13] we have shown that/.t-calpain 
co-purified with a PKC activity after chromatography on hy- 
drophobic and anion-exchange columns. In the continuity of 
these prior studies we report here, for the first time, the exis- 
tence of a 190 kDa complex constituted by the association of 
a/t-calpain molecule with a cPKC~ molecule, the most univer- 
sally expressed PKC amongst the various members of the PKC 
family. The reality of this complex is based, firstly, on results 
obtained both by gel filtration and by non-denaturing gel elec- 
trophoresis. Data from these two methods how that/z-calpain 
and the co-purifying PKC are associated in a complex with an 
apparent molecular weight of 190 kDa. 
By using SDS gel-electrophoresis and immuno-blotting it 
appears that this complex is composed of one/z-calpain mole- 
cule (110 kDa) and of one PKC~ molecule (80 kDa). This 
association seems to be very specific, because throughout dif- 
ferent extractions, biochemical tests with co-factors always re- 
vealed a conventional activity and Western blotting always 
indicated that amongst he cPKCs only the isoenzyme ~ was 
selectively associated to/t-calpain. These data support evidence 
that this complex is not due to an accidental ssociation during 
homogenisation f the tissue but corresponds to a native form. 
The existence of this specific omplex is also reinforced by the 
immunohistochemical analysis howing a co-localization of/t- 
calpain and cPKC~ at the plasma membrane level. This co- 
localization of/~-calpain and PKC~ on plasma membrane 
agrees with our previous tudy showing that p-calpain and its 
associated PKC were co-precipitated bya 200,000 x g centrifu- 
kDa 
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Fig. 4. Immunoblot analysis of cPKC isoenzymes obtained after 
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Fig. 5. (A) Non-denaturing polyacrylamide g l electrophoresis of the 
fractions obtained on Q-Sepharose and containing the p-calpain and 
PKC activities. (B) SDS-PAGE of the protein band indicated by an 
arrow in (A). Immunoblotting obtained after separation by SDS- 
PAGE; (C)/z and m-calpain. (D) PKC0~ , fl and y. The sizes of the 
marker proteins are indicated in kilodaltons. 
gation of the 100,000 x g supernatant [12]. Therefore, in this 
previous report, we suggested that these two enzymes were 
linked to light plasma vesicles obtained uring cell homogenisa- 
tion [12]. 
Concerning the molecular interactions between /.t-calpain 
and PKC~, it appears that binding between these two enzymes 
does not depend on calcium because isolation of the complex 
is carried out with high concentrations of EGTA. Further, this 
complex was isolated without addition of phosphatidylserine 
and diacylglycerol which are activators of PKC~, indicating 
that conformational modification of this kinase by these effec- 
tors does not seem to be required for binding of PKC~ to 
/~-calpain. 
As regards the relationships between/.t-calpain d PKC~ 
inside this complex, two major possibilities can be considered. 
Firstly, cPKCct could be involved in phosphorylation of/~- 
calpain. In vitro, phosphorylation f a cardiac alpain has been 
reported [23], but attempts to detect phosphorylation f~t and 
m-calpains in a leukemia cell line have been unsuccesful [24]. 
Secondly, cPKCc~ is cleaved in vitro by/z-calpain in the V3 
hinge region to generate two types of catalytic fragments 
(PKM) of 45 and 46 kDa [25]. Therefore, cPKCct appears as 
a potential substrate for/l-calpain. Finally, it will be interesting 
to study whether or not this p-catpain-PKC~ complex is pres- 
ent in other tissues than skeletal muscle. Indeed, recent results 
have shown an implication of PKM in different cellular proc- 
esses [26-32], so in this perspective, the existence of a/z-calpain- 
PKC~ complex in various tissues will be of considerable inter- 
est. 
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Fig. 6. Immunolocalisation of/z-calpain (A) and PKC~ (B) in rabbit 
skeletal muscle. Scale white bars (lower right) are 5/~m. 
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